Distribution of high-risk HPV types in Yugoslav women with cervical neoplasia

Journal of B.U.ON.

Volumn 7, Issue 3, 2002, Pages 251-256

  Stojanović, Jelena ^a   Magic Z ^a   Milacic M ^a   Nenadic D ^a   Stanimirovic B ^a   Vukicevic D ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

Cervical cancer; Human papillomavirus; Polymerase chain reaction; Risk factors; Squamous intraepithelial lesion

Indexed keywords

VIRUS DNA;

ADULT; AGAR GEL ELECTROPHORESIS; AGE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; PARITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROPHYLAXIS; RESIDENTIAL HOME; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS; YUGOSLAVIA;

EID: 0036662242     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Stanimirović B, Kuljić-Kapulica N, Antić N, Stanimirović V, Vasiljević M, Popović-Lazić J. HPV typing in cervical squamous intraepithelial lesions (SIL)-our experience after 1000 studied patients. Arch Oncol 1999; 7: 43-48.
2. Lungu O, Wei Sun X, Wright TC, Ferenczy A, Richart RM, Silverstein S. A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol 1995; 85: 337-342.
3. Cuzick J, Sasieni P, Davies P et al. A systematic review of the role of human papillomavirus testing within a cervical screening programe. Health Technol Assessment 1999; 3: 1-11.
4. Francis DA, Schmid SI, Howley PM. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J Virol 2000; 74: 2679-2686.
5. Kruger-Kjær S, van der Brule AJC, Svare EI. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer 1998; 76: 613-619.
6. Noller KL. Incidence and demographic trends in cervical neoplasia. Am J Obstet Gynecol 1996; 175: 1088-1090.
7. Syrjänen KJ, Syrjänen SM. Human papillomavirus (HPV) typing as an adjunct to cervical cancer screening. Cytopathology 1999; 10: 8-15.
8. Sigurdsson K, Arnadottir T, Snorradottir M, Benediktsdottir K, Saemundsson H. Human papillomavirus (HPV) in an Icelandic population: The role of HPV DNA testing based on hybrid capture assays among women with screen-detected abnormal Pap smears. Int J Cancer 1997; 72: 446-452.
9. Baay MFD, Quint WGV, Koudstaal J et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745-747.
10. Sambrook J, Fritsch EF, Maniatis T. Preparation of organic reagents. In: Nolan C (ed). Molecular cloning; a Laboratory Manual (2nd edn). Cold Spring Harbor Laboratory Press, New York, 1989: B4-B5.
11. Shlay JC, Dunn T, Byers T, Baron AE, Douglas JM. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol 2000; 96: 410-416.
12. Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol 1996; 175: 1091-1098.
13. Kjær SK, van den Brule AJC, Bock JE et al. Human papillomavirus- the most significant risk determinant of cervical intraepithelial neoplasia. A population-based prospective cohort study from Copenhagen. Int J Cancer 1996; 65: 601-606.
14. Cox JT. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. JAMA 1999; 281: 1645-1647.
15. Parker MF, Sausville EA, Birrer MJ. Basic biology and biochemistry of gynecologic cancer. In: Hoskins WJ, Perez CA, Young RC (eds). Principles and practice of gynecologic oncology (2nd edn). Lippincott-Raven Publishers, Philadelphia, 1997; pp 61-82.
16. Schneider A, Hoyer H, Lotz B et al. Screening for high-grade cervical intraepithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000; 89: 529-534.
17. Paraskevaidis E, Malamou-Mitsi V, Koilopoulos G et al. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing. Gynecol Oncol 2001; 82: 355-359.
18. Smita J, Tseng CJ, Horng SG et al. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 2001; 82: 177-180.
19. Fait G, Kupferminc JM, Daniel Y et al. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal Pap smears before colposcopy referral. Gynecol Oncol 2000; 79: 177-180.
20. Matsukura T, Sugase M. Relationships between 80 human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: association and causality. Virology 2001; 283, 139-147.
21. Stanimirović B, Grob R, Rüdlinger R. Carcinoma of the cervix uteri and risk factors. Eur J Gynaec Oncol 1990; 1: 51-56.